|

Psilocybin (Usona Institute) Clinical Trials

1 actively recruiting trial

Also known as: Psilocybin

Pipeline

Phase 1: 1

Top Sponsors

  • Medical University of Vienna1

Indications

  • Anhedonia1
  • Depression - Major Depressive Disorder1
  • Depression1

Other1 trial

Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.